Airway Stent Market Report 2024

This Airway Stent market report covers industry characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The airway stent market size has grown strongly in recent years. It will grow from $9.3 billion in 2023 to $9.98 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to several factors, including the rising incidence of respiratory diseases, advancements in diagnostic techniques, an aging population, increased awareness and access to healthcare, and an expansion in surgical and interventional procedures.

The airway stent market size is expected to see strong growth in the next few years. It will grow to $13.25 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to factors such as an expanding aging population, enhancements in healthcare infrastructure, increased focus on managing chronic respiratory conditions, greater awareness of respiratory health, and a rise in outpatient and ambulatory procedures. Major trends expected include technological advancements, the development of minimally invasive procedures, innovations in medical technology, bioresorbable stents, and advanced self-expanding materials.

The increasing prevalence of lung diseases and respiratory disorders is anticipated to drive the growth of the airway stent market. Lung diseases and respiratory disorders encompass a range of conditions that affect the lungs and respiratory system, impairing breathing and lung function. This rise in prevalence is attributed to factors such as rising pollution levels, smoking, exposure to environmental toxins, and an aging population, with lifestyle changes and genetic factors also playing a role. Airway stents help address these issues by providing structural support to the airways, relieving obstructions, and improving airflow in conditions like tracheal stenosis or bronchial tumors. For example, data from the National Center for Health Statistics (NCHS) in May 2024 shows that the prevalence of current asthma among U.S. adults increased from 8.4% in 2021 to 8.7% in 2022. Additionally, asthma episodes in the past year for this age group rose from 3.3% in 2021 to 3.7% in 2022. Consequently, the growing prevalence of lung diseases and respiratory disorders is expected to boost the airway stent market.

Leading companies in the airway stent market are advancing technologies, such as the self-expanding Y-shaped stent system, to enhance patient outcomes and manage complex airway conditions more effectively. The self-expanding Y-shaped stent system is designed to support and maintain airway patency in patients with tracheal or bronchial stenosis, expanding automatically to fit the airway anatomy. For instance, in February 2022, Micro-Tech Endoscopy, a US-based company specializing in endoscopic solutions, introduced the first self-expanding tracheobronchial nitinol Y-stent. This stent is intended for treating malignant neoplasms at the tracheobronchial carina and features a low-profile delivery system, a silicone cover to prevent tumor ingrowth, and repositioning sutures for easy adjustment or removal. Its flexible design and nitinol self-expanding technology aim to provide effective relief for patients with malignant tracheobronchial strictures.

In August 2023, Theken Companies, a US-based medical device manufacturer known for its innovative orthopedic and spinal solutions, acquired VisionAir Solutions from Cleveland Clinic for an undisclosed amount. This acquisition aims to bolster Theken Companies' portfolio of advanced airway management technologies, expand its presence in the medical device sector, and stimulate growth by broadening its product range. Theken Companies seeks to enhance patient outcomes in airway management through this integration. VisionAir Solutions, a US-based provider, specializes in advanced airway management technologies.

Major companies operating in the airway stent market are Medtronic Plc, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Teleflex Incorporated, Cook Medical, KARL STORZ SE & Co. KG, Merit Medical Systems, MICRO-TECH (Nanjing) Co. Ltd., Taewoong Medical Co. Ltd., Alvimedica Medical Technologies Inc, M.I. Tech Co. Ltd., Fuji Systems Corporation, Pnn Medical A/S, Endo-Flex GmbH, InSitu Technologies, QualiMed Innovative Medizinprodukte GmbH, Novatech SA, Boston Medical Products Inc., HOOD LABORATORIES, Meditek Systems Pvt. Ltd., Kapitex Healthcare Ltd, S&G Biotech Inc., AndraTec GmbH, Allium Medical Solutions Ltd., Medi-Globe GmbH, Bess medizintechnik GmbH.

North America was the largest region in the airway stent market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the airway stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the airway stent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

An airway stent is a medical device designed to maintain open airways, ensuring proper airflow for individuals with narrowed or obstructed airways due to conditions like tumors, strictures, or other respiratory disorders. They are used to treat obstructions in the trachea, bronchi, or larynx, improving breathing and lung function.

The primary types of airway stents include tracheal stents, laryngeal stents, and bronchial stents. Tracheal stents specifically support and keep the trachea open, addressing issues such as tumors or strictures that narrow or obstruct this crucial airway. These stents come in various forms, including expandable and non-expandable options, and are made from materials such as metal, silicon, or hybrid substances. They are used in diverse settings including hospitals, clinics, home healthcare, ambulatory surgical centers, laboratories, and research facilities.

The airway stent market research report is one of a series of new reports that provides airway stent market statistics, including airway stent industry global market size, regional shares, competitors with an airway stent market share, detailed airway stent market segments, market trends and opportunities, and any further data you may need to thrive in the airway stent industry. This airway stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The airway stent market consists of sales of Y-shaped stents, biodegradable stents, and uncovered stents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.